Cite
HARVARD Citation
Tricou, V. et al. (2020). Safety and immunogenicity of a single dose of a tetravalent dengue vaccine with two different serotype-2 potencies in adults in Singapore: A phase 2, double-blind, randomised, controlled trial. Vaccine. 38 (6), pp. 1513-1519. [Online].